These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 30086458)
1. Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells. Cun J; Yang Q Biomed Pharmacother; 2018 Nov; 107():117-128. PubMed ID: 30086458 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression. Zhu J; Zou Z; Nie P; Kou X; Wu B; Wang S; Song Z; He J Cell Death Dis; 2016 Nov; 7(11):e2454. PubMed ID: 27809310 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines. Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600 [TBL] [Abstract][Full Text] [Related]
4. Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy. Zhu QN; Renaud H; Guo Y Hereditas; 2018; 155():17. PubMed ID: 29371858 [TBL] [Abstract][Full Text] [Related]
5. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer. Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905 [TBL] [Abstract][Full Text] [Related]
6. Corylin sensitizes breast cancer cells to overcome tamoxifen resistance by regulating OAS1/miR-22-3p/SIRT1 axis. Che L; Yang H; Wang D; Liu S Acta Biochim Pol; 2021 Nov; 68(4):757-764. PubMed ID: 34731560 [TBL] [Abstract][Full Text] [Related]
7. Overexpression miR-24-3p repressed Bim expression to confer tamoxifen resistance in breast cancer. Han X; Li Q; Liu C; Wang C; Li Y J Cell Biochem; 2019 Aug; 120(8):12966-12976. PubMed ID: 31001849 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop. Li X; Wu Y; Liu A; Tang X Tumour Biol; 2016 Nov; 37(11):14733-14743. PubMed ID: 27629141 [TBL] [Abstract][Full Text] [Related]
9. A novel tumor suppressor ZBTB1 regulates tamoxifen resistance and aerobic glycolysis through suppressing Zhang P; Yang Y; Qian K; Li L; Zhang C; Fu X; Zhang X; Chen H; Liu Q; Cao S; Cui J J Biol Chem; 2020 Oct; 295(41):14140-14152. PubMed ID: 32690611 [TBL] [Abstract][Full Text] [Related]
10. The investigation of miR-221-3p and PAK1 gene expressions in breast cancer cell lines. Ergun S; Tayeb TS; Arslan A; Temiz E; Arman K; Safdar M; Dağlı H; Korkmaz M; Nacarkahya G; Kırkbeş S; Oztuzcu S Gene; 2015 Jan; 555(2):377-81. PubMed ID: 25447917 [TBL] [Abstract][Full Text] [Related]
11. LINC01433/miR-2116-3p/MYC Feedback Loop Promotes Cell Proliferation, Migration, and the Epithelial-Mesenchymal Transition in Breast Cancer. Wu M; Wu W; Ding J; Yang J Cancer Biother Radiopharm; 2019 Aug; 34(6):388-397. PubMed ID: 30939038 [No Abstract] [Full Text] [Related]
12. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data. Wang YW; Zhang W; Ma R Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395 [TBL] [Abstract][Full Text] [Related]
13. Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells. Zhou Q; Zeng H; Ye P; Shi Y; Guo J; Long X Anticancer Drugs; 2018 Jul; 29(6):539-548. PubMed ID: 29557813 [TBL] [Abstract][Full Text] [Related]
14. Prospective lncRNA-miRNA-mRNA regulatory network of long non-coding RNA LINC00968 in non-small cell lung cancer A549 cells: A miRNA microarray and bioinformatics investigation. Li DY; Chen WJ; Luo L; Wang YK; Shang J; Zhang Y; Chen G; Li SK Int J Mol Med; 2017 Dec; 40(6):1895-1906. PubMed ID: 29039552 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ. Lü M; Ding K; Zhang G; Yin M; Yao G; Tian H; Lian J; Liu L; Liang M; Zhu T; Sun F Sci Rep; 2015 Mar; 5():8735. PubMed ID: 25736597 [TBL] [Abstract][Full Text] [Related]
16. miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A. Ikeda K; Horie-Inoue K; Ueno T; Suzuki T; Sato W; Shigekawa T; Osaki A; Saeki T; Berezikov E; Mano H; Inoue S Sci Rep; 2015 Aug; 5():13170. PubMed ID: 26255816 [TBL] [Abstract][Full Text] [Related]
17. LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer. Ma Y; Bu D; Long J; Chai W; Dong J J Cell Physiol; 2019 Mar; 234(3):2880-2894. PubMed ID: 30203615 [TBL] [Abstract][Full Text] [Related]
18. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics. Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776 [TBL] [Abstract][Full Text] [Related]
19. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4. Feng X; Zhao L; Gao S; Song X; Dong W; Zhao Y; Zhou H; Cheng L; Miao X; Jia L Gene; 2016 Mar; 578(2):232-41. PubMed ID: 26701615 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance. Martin EC; Conger AK; Yan TJ; Hoang VT; Miller DF; Buechlein A; Rusch DB; Nephew KP; Collins-Burow BM; Burow ME FEBS Lett; 2017 Jan; 591(2):382-392. PubMed ID: 28008602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]